This is a preview of subscription content, log in via an institution to check access.
Notes
British pounds
References
NICE. NICE recommends treatment for severe Crohn's disease. Internet Document : 10 Jul 2015. Available from: URL: http://www.nice.org.uk/news/press-and-media/nice-recommends-treatment-for-severe-crohn?s-disease
NICE. NICE recommends edoxaban tosylate (Lixiana) for treating and preventing potentially fatal blood clots. Internet Document : 12 Jul 2015. Available from: URL: http://www.nice.org.uk/news/press-and-media/nice-recommends-edoxaban-tosylate-lixiana-for-treating-and-preventing-potentially-fatal-blood-clots
Rights and permissions
About this article
Cite this article
NICE recommends vedolizumab for Crohn's disease. PharmacoEcon Outcomes News 732, 34 (2015). https://doi.org/10.1007/s40274-015-2300-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-015-2300-x